Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05670496 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Aug 1, 2026 → Aug 1, 2027
See other at-risk trials from National Institute on Deafness and Other Communication Disorders (NIDCD)

Record History

The 50 most recent of 68 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 1, 2026 to Aug 1, 2027v68
  2. 2 versions Re-verified since Mar 5, 2026, no change to tracked fieldsv66-v67
  3. Eligibility criteria expanded, about 111 words Study description expanded, about 46 wordsv65 Show 1 more changeShow less
    • Study description expanded, about 46 words

    See this version in full on ClinicalTrials.gov ↗

  4. 2 versions Re-verified since Oct 10, 2025, no change to tracked fieldsv63-v64
  5. Primary completion date: Aug 1, 2025 to Aug 1, 2026v62
Show 43 earlier versionsHide 43 earlier versions
  1. 6 versions Re-verified since Sep 7, 2024, no change to tracked fieldsv56-v61
  2. Primary completion date: Aug 1, 2024 to Aug 1, 2025v55
  3. 2 versions Re-verified since Jul 30, 2024, no change to tracked fieldsv53-v54
  4. Study title expanded, about 4 wordsv52 See this version in full on ClinicalTrials.gov ↗
  5. Eligibility criteria expanded, about 6 words Study description expanded, about 16 wordsv51 Show 1 more changeShow less
    • Study description expanded, about 16 words

    See this version in full on ClinicalTrials.gov ↗

  6. 4 versions Re-verified since Nov 4, 2023, no change to tracked fieldsv47-v50
  7. Primary completion date: Aug 1, 2023 to Aug 1, 2024v46
  8. 2 versions Re-verified since Mar 25, 2023, no change to tracked fieldsv44-v45
  9. Start date changed from estimate of Mar 14, 2023 to Mar 8, 2023v43
  10. Start date: Mar 13, 2023 to Mar 14, 2023v42
  11. Start date: Mar 12, 2023 to Mar 13, 2023v41
  12. Start date: Mar 9, 2023 to Mar 12, 2023v40
  13. Start date: Mar 8, 2023 to Mar 9, 2023v39
  14. Start date: Mar 7, 2023 to Mar 8, 2023v38
  15. Start date: Mar 6, 2023 to Mar 7, 2023v37
  16. Trial status: Not Yet Recruiting to Recruiting Start date: Mar 5, 2023 to Mar 6, 2023 · Site details revisedv36 Show 2 more changesShow less
    • Start date: Mar 5, 2023 to Mar 6, 2023
    • Site details revised
  17. Start date: Mar 2, 2023 to Mar 5, 2023v35
  18. Start date: Feb 28, 2023 to Mar 2, 2023v34
  19. Start date: Feb 24, 2023 to Feb 28, 2023v33
  20. Start date: Feb 23, 2023 to Feb 24, 2023v32
  21. Start date: Feb 22, 2023 to Feb 23, 2023v31
  22. Start date: Feb 21, 2023 to Feb 22, 2023v30
  23. Start date: Feb 20, 2023 to Feb 21, 2023v29
  24. Start date: Feb 19, 2023 to Feb 20, 2023v28
  25. Start date: Feb 16, 2023 to Feb 19, 2023v27
  26. Start date: Feb 15, 2023 to Feb 16, 2023v26
  27. Start date: Feb 14, 2023 to Feb 15, 2023v25
  28. Start date: Feb 13, 2023 to Feb 14, 2023v24
  29. Start date: Feb 12, 2023 to Feb 13, 2023v23
  30. Start date: Feb 9, 2023 to Feb 12, 2023v22
  31. Start date: Feb 8, 2023 to Feb 9, 2023v21
  32. Start date: Feb 6, 2023 to Feb 8, 2023v20
  33. Start date: Feb 5, 2023 to Feb 6, 2023v19
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: People with hearing, balance, and taste, smell, voice, speech, language, and other Ear, Nose, and Throat (ENT) disorders may seek treatment at the National Institute on Deafness and Other Communication Disorders (NIDCD). Some of these people may benefit from enrolling in the NIDCD intramural research program to receive their care. Enrolling will also allow investigators to collect participants clinical data and specimens for future research. Objective: This natural history study has 2 goals: (1) to collect data and specimens that may be used for research; and (2) to evaluate participants who may be candidates for other research studies. Eligibility: People aged 2 years or older with a hearing, balance, and communication disorder. Those at risk or who are suspected of having such a disorder are also eligible. Design: Participants will be screened. Their medical records will be reviewed. Participants will agree to have their medical data used for research. Specimens such as blood or other tissue samples may also be used for research. All data and specimens will be collected during their routine care visits. All tests done will be the normal care for each participant s condition. No tests will be done solely for research. Some of these tests may require blood or tissue samples. Some may use special tools to test hearing and balance. Some may test heart or lung function. These tests may also include different types of imaging scans. All tests will be explained. Participants may ask questions at any time. Participants may remain in this study for up to 2 years. If they need further care, they may sign a new consent. ...
Trial Details
NCT Number NCT05670496
Lead Sponsor National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions Hearing Loss, Deafness
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov